Innovation + Impact E-newsletter January 2021

Join Global Health on Follow CII on JANUARY 2021 FEATURE   LifeBank Founder Temie Giwa-Tubosun Wins 2020 Global Citizen Prize LifeBank Founder Temie Giwa-Tubosun has been awarded the 2020 Global Citizen Prize for Business Leader, and was presented the award by singer activist John Legend. LifeBank delivers blood and other medical supplies to hospital patients for safer deliveries and pivoted to deliver oxygen and other critical COVID-19 supplies. LifeBank has created life-saving impact in Nigeria and has recently expanded to Kenya. LifeBank is the first investee of Financing for MOMs, a partnership with the Development Finance Corporation (DFC), Merck for Mothers, and Credit Suisse as well as USAID. LifeBank was also featured in The New Yorker for the "Blood Rider" documentary on one of their motorcycle drivers.        INNOVATION     Zika GCD innovator raises $85 million in Series E financing Premise Data, a Zika Grand Challenge innovator, announced that they have raised $85 million in Series E financing to expand their platform capabilities and global network. Premise owns a broad cyber-physical market intelligence platform, making it possible to gather and analyze real-time data from a global network. Through the Zika Grand Challenge, Premise launched pilot programs where communities helped collect mosquito monitoring information in areas with high Zika prevalence. During COVID-19, Premise played a critical role in supporting a variety of public and private organizations and has collected over 150M data points related to the pandemic.          MARKET SHAPING     CII's Market Shaping Training now online CII is excited to share our first interactive, e-learning courses on content areas relevant to our work. CII's Market Shaping and Introduction Planning E-Learning Course is the first in this series. This one-hour course will prepare learners to utilize market shaping and strategic planning to improve access to global health products. From this course, learners will understand how to apply the Market Shaping Primer framework to facilitate more efficient markets for health impact; and the Ready, Set Launch tools for country-specific scale-up of global health products, starting from country prioritization to an operational launch plan. INNOVATION     Nature's 10 list features CII innovators   Nature's 10 list explores key developments in science and some of the people who played important parts in these milestones. The 2020 list featured Adi Utarini, a public health researcher from Indonesia, who in collaboration with Zika Grand Challenge winner World Mosquito Program (WMP), led a research program to help eliminate dengue fever in parts of a large Indonesian city. Utarini and her colleagues conducted a randomized control trial using Wolbachia-infected mosquitoes— modified to stop them from transmitting the virus, and managed to cut cases of dengue fever by 77%. Epidemiologists hailed the result as staggering — and a long-sought win against a virus that has plagued many countries, especially lower-income nations in Asia, Africa and South America.    VIRTUAL EVENTS February 1, 2021 A Catalyst for Humanity': A Conversation with Isabel Wilkerson The Forum at the Harvard T.H. Chan School of Public Health February 2, 2021 The Power of CDFIs for Inclusive Economic Recovery The Clinton Health Access Initiative February 4, 2021 Expanding Digital Health Innovation in Emerging Markets Resonance February 5, 2021 What Will It Take to Achieve Universal Health? Center for Global Development February 11, 2021 Applications of Finance in Global Health MarketLinks CII NEWS IPM IPM Welcomes WHO's Recommendation for Dapivirine Vaginal Ring as New Women's HIV Prevention Option January 27, 2021 ICTWorks USAID Vision for Systems-Level Action in Digital Health Solutions January 20, 2021 Devex Q&A: The role of transparency in preventing maternal and child deaths January 18, 2021 USAID Managing Machine Learning Projects in International Development: A Practical Guide January 12, 2021  NEWS Humanitarian Grand Challenge Innovations to transform humanitarian aid in the wake of the COVID-19 pandemic January 13, 2021 Unitaid Unitaid looks to invest in better tools to prevent and treat postpartum hemorrhage January 27, 2021 GSK GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine January 27, 2021 Devex New alliance aims to draw unheard voices into ethical AI conversation January 29, 2021  WHAT WE'RE READING USAID CII 2020 Impact Brief NBER The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks StatNews The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race World Economic Forum COVID Response Alliance for Social Entrepreneurs USAID BluePrint for Global health Resilience FSG Seizing Opportunity: A Practitioner's Guide to Supporting Market Systems Change toward Inclusion and Equity CII Staff Spotlight       Will Durbin, Lead Innovation Advisor Will Durbin is the Lead Innovation Advisor at CII. This is his first stint in the US Government. Previously, Will got the political bug and worked on a number of campaigns right after college. He then worked at an air pollution consulting firm and at two small NGOs before living for a time in Guatemala and Nicaragua. After graduate school, he worked at the World Bank, moved to California to help a friend with a startup, and helped launch a blood donation tool at Facebook. He holds a BA in Ethics, Politics & Economics from Yale and a Master's in Public Affairs with a concentration in health policy from Princeton. He enjoys nature, hiking, and music. Read Will's full interview here. The Center for Innovation and Impact (CII) in USAID's Bureau for Global Health encourages business-minded approaches and accelerates impact against some of the world's most important health issues. CII invests seed capital in the most promising efforts and applies a rigorous, market-oriented approach to cut the time it takes to transform ideas from the drawing board into impact on the ground.     Stay Connected with USAID Global Health         Unsubscribe | Update Your E-mail Address | USAID.gov | Privacy Policy   If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. Ogilvy is sending these announcements on behalf of USAID's Bureau for Global Health. Ogilvy is located at 1111 19th St. NW, Washington, DC 20036 • (202) 729-4000